It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A brain-computer interface (BCI) enables users to control devices with their minds. Despite advancements, non-invasive BCIs still exhibit high error rates, prompting investigation into the potential reduction through concurrent targeted neuromodulation. Transcranial focused ultrasound (tFUS) is an emerging non-invasive neuromodulation technology with high spatiotemporal precision. This study examines whether tFUS neuromodulation can improve BCI outcomes, and explores the underlying mechanism of action using high-density electroencephalography (EEG) source imaging (ESI). As a result, V5-targeted tFUS significantly reduced the error in a BCI speller task. Source analyses revealed a significantly increase in theta and alpha activities in the tFUS condition at both V5 and downstream in the dorsal visual processing pathway. Correlation analysis indicated that the connection within the dorsal processing pathway was preserved during tFUS stimulation, while the ventral connection was weakened. These findings suggest that V5-targeted tFUS enhances feature-based attention to visual motion.
Transcranial focused ultrasound (tFUS) is a non-invasive brain modulation technology with high spatiotemporal specificity. Here, authors found tFUS can significantly enhance a brain-computer interface speller by delivering low-intensity tFUS to visual cortex during the task in naïve human subjects.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Carnegie Mellon University, Department of Biomedical Engineering, Pittsburgh, USA (GRID:grid.147455.6) (ISNI:0000 0001 2097 0344)
2 Carnegie Mellon University, Department of Biomedical Engineering, Pittsburgh, USA (GRID:grid.147455.6) (ISNI:0000 0001 2097 0344); Boston University, Department of Biomedical Engineering, Boston, USA (GRID:grid.189504.1) (ISNI:0000 0004 1936 7558)
3 Carnegie Mellon University, Department of Biomedical Engineering, Pittsburgh, USA (GRID:grid.147455.6) (ISNI:0000 0001 2097 0344); Carnegie Mellon University, Neuroscience Institute, Pittsburgh, USA (GRID:grid.147455.6) (ISNI:0000 0001 2097 0344)